These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 29263650)
1. Redox-responsive and pH-sensitive nanoparticles enhanced stability and anticancer ability of erlotinib to treat lung cancer in vivo. Tan S; Wang G Drug Des Devel Ther; 2017; 11():3519-3529. PubMed ID: 29263650 [TBL] [Abstract][Full Text] [Related]
2. Designed Synthesis of Lipid-Coated Polyacrylic Acid/Calcium Phosphate Nanoparticles as Dual pH-Responsive Drug-Delivery Vehicles for Cancer Chemotherapy. Wang X; Zhang M; Zhang L; Li L; Li S; Wang C; Su Z; Yuan Y; Pan W Chemistry; 2017 May; 23(27):6586-6595. PubMed ID: 28218434 [TBL] [Abstract][Full Text] [Related]
3. Thermo-sensitive chitosan copolymer-gold hybrid nanoparticles as a nanocarrier for delivery of erlotinib. Fathi M; Sahandi Zangabad P; Barar J; Aghanejad A; Erfan-Niya H; Omidi Y Int J Biol Macromol; 2018 Jan; 106():266-276. PubMed ID: 28802850 [TBL] [Abstract][Full Text] [Related]
4. Synergistic Combination Chemotherapy of Lung Cancer: Cisplatin and Doxorubicin Conjugated Prodrug Loaded, Glutathione and pH Sensitive Nanocarriers. Jin Y; Wang Y; Liu X; Zhou J; Wang X; Feng H; Liu H Drug Des Devel Ther; 2020; 14():5205-5215. PubMed ID: 33268983 [TBL] [Abstract][Full Text] [Related]
5. HA/HSA co-modified erlotinib-albumin nanoparticles for lung cancer treatment. Shen Y; Li W Drug Des Devel Ther; 2018; 12():2285-2292. PubMed ID: 30087553 [TBL] [Abstract][Full Text] [Related]
6. Non-small cell lung cancer combination therapy: Hyaluronic acid modified, epidermal growth factor receptor targeted, pH sensitive lipid-polymer hybrid nanoparticles for the delivery of erlotinib plus bevacizumab. Pang J; Xing H; Sun Y; Feng S; Wang S Biomed Pharmacother; 2020 May; 125():109861. PubMed ID: 32070872 [TBL] [Abstract][Full Text] [Related]
7. Combination Chemotherapy of Lung Cancer - Co-Delivery of Docetaxel Prodrug and Cisplatin Using Aptamer-Decorated Lipid-Polymer Hybrid Nanoparticles. Wu R; Zhang Z; Wang B; Chen G; Zhang Y; Deng H; Tang Z; Mao J; Wang L Drug Des Devel Ther; 2020; 14():2249-2261. PubMed ID: 32606595 [TBL] [Abstract][Full Text] [Related]
8. Microparticles containing erlotinib-loaded solid lipid nanoparticles for treatment of non-small cell lung cancer. Bakhtiary Z; Barar J; Aghanejad A; Saei AA; Nemati E; Ezzati Nazhad Dolatabadi J; Omidi Y Drug Dev Ind Pharm; 2017 Aug; 43(8):1244-1253. PubMed ID: 28323493 [TBL] [Abstract][Full Text] [Related]
9. CS/PAA@TPGS/PLGA nanoparticles with intracellular pH-sensitive sequential release for delivering drug to the nucleus of MDR cells. Wang YY; Zhang DD; Kong YY; Shao LL; Zhang FY; Gao Y; Mu X; Wang J; Li HF; Yu SQ; Xu Q Colloids Surf B Biointerfaces; 2016 Sep; 145():716-727. PubMed ID: 27289313 [TBL] [Abstract][Full Text] [Related]
10. Tailor-made pH-sensitive polyacrylic acid functionalized mesoporous silica nanoparticles for efficient and controlled delivery of anti-cancer drug Etoposide. Saroj S; Rajput SJ Drug Dev Ind Pharm; 2018 Jul; 44(7):1198-1211. PubMed ID: 29412022 [TBL] [Abstract][Full Text] [Related]
11. Pulmonary Delivery of Reactive Oxygen Species/Glutathione-Responsive Paclitaxel Dimeric Nanoparticles Improved Therapeutic Indices against Metastatic Lung Cancer. Tian X; Bera H; Guo X; Xu R; Sun J; He Z; Cun D; Yang M ACS Appl Mater Interfaces; 2021 Dec; 13(48):56858-56872. PubMed ID: 34806372 [TBL] [Abstract][Full Text] [Related]
12. Non-small cell lung cancer-targeted, redox-sensitive lipid-polymer hybrid nanoparticles for the delivery of a second-generation irreversible epidermal growth factor inhibitor-Afatinib: In vitro and in vivo evaluation. Wang J; Su G; Yin X; Luo J; Gu R; Wang S; Feng J; Chen B Biomed Pharmacother; 2019 Dec; 120():109493. PubMed ID: 31586902 [TBL] [Abstract][Full Text] [Related]
13. Improved camptothecin encapsulation and efficacy by environmentally sensitive block copolymer/chitosan/fucoidan nanoparticles for targeting lung cancer cells. Don TM; Hong YT; Jheng PR; Chuang EY; Huang YC Int J Biol Macromol; 2024 Oct; 277(Pt 2):133901. PubMed ID: 39038585 [TBL] [Abstract][Full Text] [Related]
14. Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles. Liu J; Cheng H; Han L; Qiang Z; Zhang X; Gao W; Zhao K; Song Y Drug Des Devel Ther; 2018; 12():3199-3209. PubMed ID: 30288024 [TBL] [Abstract][Full Text] [Related]
16. Lung cancer targeted therapy: Folate and transferrin dual targeted, glutathione responsive nanocarriers for the delivery of cisplatin. Tan S; Wang G Biomed Pharmacother; 2018 Jun; 102():55-63. PubMed ID: 29549729 [TBL] [Abstract][Full Text] [Related]
17. PEGylated polypeptide lipid nanocapsules to enhance the anticancer efficacy of erlotinib in non-small cell lung cancer. Kim J; Ramasamy T; Choi JY; Kim ST; Youn YS; Choi HG; Yong CS; Kim JO Colloids Surf B Biointerfaces; 2017 Feb; 150():393-401. PubMed ID: 27825759 [TBL] [Abstract][Full Text] [Related]
18. Nanoparticles based on complex of berberine chloride and polymethacrylic or polyacrylic acid with antioxidant and in vitro antitumor activities. Stoyanova N; Ignatova M; Manolova N; Rashkov I; Toshkova R; Georgieva A Int J Pharm; 2020 Jun; 584():119426. PubMed ID: 32445907 [TBL] [Abstract][Full Text] [Related]
19. Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy. He Y; Su Z; Xue L; Xu H; Zhang C J Control Release; 2016 May; 229():80-92. PubMed ID: 26945977 [TBL] [Abstract][Full Text] [Related]
20. Prostate-specific membrane antigen targeted, glutathione-sensitive nanoparticles loaded with docetaxel and enzalutamide for the delivery to prostate cancer. Chen Y; Xu Z; Lu T; Luo J; Xue H Drug Deliv; 2022 Dec; 29(1):2705-2712. PubMed ID: 35980107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]